Gender differences in blood thrombogenicity in hyperlipidemic patients and response to pravastatin (Q73022227)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Gender differences in blood thrombogenicity in hyperlipidemic patients and response to pravastatin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

G Dangas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

D A Smith

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J J Badimon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A H Unger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J H Shao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

P Meraj

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A M Cohen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

D Levine

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J A Ambrose

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498131%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

639-643

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498131%20AND%20SRC:MED&resulttype=core&format=json

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900408-7

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900408-7

Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900408-7

Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900408-7

Thromboembolic stroke in young women. A European case-control study on oral contraceptives. Transnational Research Group on Oral Contraceptives and the Health of Young Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900408-7

Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900408-7

Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900408-7

Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900408-7

Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900408-7

Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900408-7

Plasma tissue plasminogen activator levels in patients with coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900408-7

Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900408-7

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900408-7

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900408-7

Effect of atorvastatin on plasma fibrinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900408-7

10.1016/S0002-9149(99)00408-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10498131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference